Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in the research of atherosclerosis.
References:
[1]. Nathalie Mesplet, et al. Analysis of eflucimibe and related impurities by highly sensitive liquid chromatograpelectrospray-tandem mass spectrometry. The Journal of Separation Science. 2003.
















